drugset / Trial / NCT02156934

Paraurethral Transplantation of Autologous Muscle Derived Stem Cells for Treatment of Stress Incontinency

NCT02156934 ↗

Phase 2 Completed 20 enrolled Royan Institute
NaSingle-groupOpen-labelTreatment

Summary

This study was designed to provide confirmation of efficacy of muscle derived stem cells (MDCs) for the treatment of SUI in women.

Timeline

Start
2014-01
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject muscle derived stem cell Cell therapy 5e+07 cells Other